No booze, better beat: study tests alcohol abstinence after AF ablation

NCT ID NCT07528729

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether staying alcohol-free for six months after a heart ablation procedure can reduce the return of atrial fibrillation (AF), a common heart rhythm problem. Researchers will enroll 414 adults who drink at least three alcoholic beverages per week and are scheduled for their first AF ablation. Participants will either receive nurse-led support to quit alcohol or continue their usual habits. The study uses a smartwatch to track heart rhythms and will also measure symptoms, quality of life, and long-term outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

alcohol abstinence (behavioral intervention)

What this could lead to

If successful, this could show that stopping alcohol for six months after ablation reduces the chance of atrial fibrillation returning, offering a simple lifestyle change to improve outcomes.

What could go wrong

This is a behavioral study with no blinding, so results may be influenced by participant awareness. The intervention requires significant commitment, and long-term benefits beyond six months are not yet known.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alcohol Abstinence atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••